# Lyphe Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lyphe-group

- Industry: Pharmaceuticals
- Headquarters: London, UK
- Website: www.lyphegroup.com
- Total disclosed funding: $6.8M
- Latest round: Series A (Jan 14, 2022)
- Investors on record: 2

## About

Founded in 2018 and based in London, UK, Lyphe Group Limited, formerly known as Ech Medical Holdco Limited, engages in the manufacturing of medicine for treating patients, and direct-to-patient digital services care with cannabis. The company was formed out of an incubator called ECH, where Lyphe span out in 2019. In the same year, the company acquired CQC license for The Medical Cannabis Clinics to open. In 2022, the company launched Lyphe Australia. In May 2022, Lyphe Group Limited raised GBP 5 million in series A funding led by new investor Leafy Tunnel, with participation from new investor Sharp Capital Advisors. Other Unspecified investors also participated in the round.

The company operates as a manufacturer of medical cannabis. Besides the products, it provides clinics, dispensing, import infrastructure, and educational services to patients, doctors, and the industry.

## Funding rounds

- Series A, Jan 14, 2022, $6.8M — Leafy Tunnel, Sharp Capital Advisors

## Investors

- Leafy Tunnel (https://capitalatlas.ai/funds/leafy-tunnel) — Series A
- Sharp Capital Advisors — Series A